50% off Premium Yearly
Palantir TechnologiesPLTRHOLDJan 28, 2026Stock price when the opinion was issued
As of Aug 21, 2026. Market Open.
Becoming a champion for individual companies owning their own data and being able to use the models themselves. Anthropic and OpenAI embedding themselves into ecosystems is like letting the fox into the henhouse. PLTR protects against that.
August 3 results showed 93% YOY growth, commercial up 150%. Best-in-class growth, strong profitability. Expensive stock, but operationalizing AI in a massive way. No dividend.
Popular name, mentioned a lot in media. Stock moves around quite a bit, volatile. Popped above 200-day MA on earnings results. Yet 200-day MA still trending lower. Valuation of ~90x forward PE, with high growth rate. But if anything goes bump in the night here, the stock will be in trouble.
Look for better risk/reward parameters. See his Top Picks.
Price target in 12 months of $182.25, long runway. Government side is massive, so fully integrated into so many defense systems around the world. Needs to strengthen enterprise side. CEO's abruptness turns people off in the way Elon Musk does. Definitely buy some here, more ~$115, and the rest ~$105.
Executing well. Increasingly employing AI in day-to-day operations. Growing use in government/defense plus strong adoption by commercial customers.
Proving it can turn demand into profit and cashflow. Revenue grew an exceptional 85% last quarter. Valuation remains her biggest concern (roughly 40x next year's sales), leaving little room for disappointment/error. Be cautious.
The only software name he owns. Beaten down because it's put in the software bucket, plus relatively expensive compared to peers. Sometimes you have to pay up for a best-in-class asset. Last quarter's numbers blew it out of the water. Growing 80% YOY, very profitable.
Accelerating commercial revenue on top of government contracts. Helping companies adopt AI.
Only drawback is that the stock's very expensive. So there's no good valuation support, and she doesn't own it.
But nothing really wrong with the story, so she wouldn't recommend a Sell. If you liked it a month ago, nothing has changed. Pretty well positioned on defense. Fundamentals are in favour of it, so she'd hold.
For these high-beta stocks, you can't be getting nervous about them. If you don't want to stomach the high volatility, look for a more diversified solution or for a stock that's less volatile.